November 11, 2013 | Israeli company Lumenis, a medical device company, is planning to raise $100 million on Nasdaq at a company value of up to $500 million (after money). “Globes” reports that the already publicly-traded company has set a target date of February 14 to return Nasdaq.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments